A cell culture startup that attracted attention last year for providing the scaffold used in the world’s second-ever artificial trachea implant has landed a $500,000 investment.
Columbus, Ohio-based Nanofiber Solutions has received a $500,000 convertible loan from state-backed business development group TechColumbus, Columbus Business First reported.
A Data-Driven Guide to Patient Access Success
A new report from Relatient, A Data-Driven Guide to Patient Access Succes, highlights how focusing on data accuracy and relevance can enhance the performance of healthcare practices.
The company’s cell culture products use polymer nanofibers to more accurately simulate the 3-D structure of human tissue.
Here’s how Nanofiber Solutions works with artificial organs: It manufactures scaffolds in the shape of a human organ and those scaffolds are then seeded with a patient’s own stem cells. Next, the scaffold is placed in a culturing device for a few days and the patient’s tissue grows on it. The patient’s organ is then removed and the artificial organ that’s grown on the scaffold is implanted into the patient.
The company, which was spun out of Ohio State University, sees a lot of promise in the artificial organs market and says its technology could be used to create scaffolds for a number of other types of hollow organs, such as intestines, blood vessels and kidneys, chief technology officer Jed Johnson told MedCity News earlier this year.
Nanofiber Solutions is looking to close a series A round of investment of between $2 million and $5 million this year, Johnson said at the time. The cash from TechColumbus could be the beginning of seeing that happen.
How to Improve Employee Benefits While Reducing Insurance Costs
Balancing healthcare benefits and insurance costs requires research. From becoming a Difference Card member to offering wellness resources, there are many ways to improve healthcare at low cost.